Aviva’s NRC Health Common Stock NRC Stock Holding History

Aviva’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,855	Closed	-$225K	–	885
2024 Q3	$225K	Sell	9,855 -4,370	-31%	-$98.7K	﹤0.01%	860
2024 Q2	$326K	Buy	+14,225	New	+$438K	﹤0.01%	871

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aviva's NRC Position: Q4 2024 in Review

Aviva sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 9,855 shares — an estimated $225K sold.

Aviva first reported a position in NRC in Q2 2024 and held it in 2 quarters. The position peaked at $326K in Q2 2024. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

Aviva reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
Aviva sold 9,855 NRC Health Common Stock shares in Q4 2024, an estimated $225K.
Aviva first reported a position in NRC Health Common Stock in Q2 2024 and held it in 2 quarters.
Aviva's NRC Health Common Stock position peaked at $326K in Q2 2024.
133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Aviva's 13F filing for Q4 2024, filed 13 Feb 2025.